Add BrightSurf on Google Email

The Lancet


Infection in breast implants

Breast implant infections can occur due to various risk factors, including capsular contraction. Experts propose diagnostic and management strategies for such problems. Antibiotics may prevent capsular contraction caused by subclinical infection.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateFeb 1, 2005

New insight into link between homocysteine and stroke

Researchers used Mendelian randomization to investigate the link between homocysteine levels and stroke risk. They found that individuals with a specific genetic variation had higher homocysteine levels and increased stroke risk, suggesting a potential role for folic acid and B vitamins in preventing strokes.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 13, 2005

Exposed: Tobacco industrys' efforts to cast doubt

A study reveals tobacco companies' strategies to counteract research linking tobacco smoke to cancer-causing mutations in the p53 gene. The industry supported studies that appeared to cast doubt on this link, raising concerns about conflicts of interest and the integrity of scientific research.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 13, 2005

OTC treatment for acne as good as antibiotics

A randomized trial involving over 650 participants found that OTC acne treatments were as effective as oral antibiotic tablets. Benzoyl peroxide was identified as the cheapest and most cost-effective treatment, with a significant difference in cost-effectiveness between regimens.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 16, 2004

Paper of the Year 2004

The Lancet's Paper of the Year 2004 exposed flaws in pharmaceutical companies and highlighted the need for an international register of randomized clinical trials. The paper also mentioned notable contributions from Richard Doll and Salim Yusuf.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 16, 2004

Thinking beyond deworming

The editorial concludes that deworming programs have substantial public health benefits and reductions in global burden of disease. Simple, effective, safe, and cheap treatments are already available, but systematic delivery requires industry, funders, and political will.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 2, 2004